UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles

Scientific reports, 2020-07, Vol.10 (1), p.11292-18, Article 11292

2020

Volltextzugriff (PDF)

Protein PEGylation for cancer therapy: bench to bedside

Journal of cell communication and signaling, 2019-09, Vol.13 (3), p.319-330

2019

Volltextzugriff (PDF)

ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells

European journal of pharmaceutical sciences, 2009-05, Vol.37 (2), p.141-150

2009

Volltextzugriff (PDF)

Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain Delivery

Journal of nanotheranostics, 2023-10, Vol.4 (4), p.463-479

2023

Volltextzugriff (PDF)

M. tuberculosis Transcription Machinery: A Review on the Mycobacterial RNA Polymerase and Drug Discovery Efforts

Life (Basel, Switzerland), 2022-11, Vol.12 (11), p.1774

2022

Volltextzugriff (PDF)

Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers

Therapeutic delivery, 2014-10, Vol.5 (10), p.1143-1163

2014

Volltextzugriff (PDF)

Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model

European journal of pharmacology, 2019-06, Vol.853, p.264-274

2019

Volltextzugriff (PDF)

Controlling Ligand Surface Density Optimizes Nanoparticle Binding to ICAM-1

Journal of pharmaceutical sciences, 2011-03, Vol.100 (3), p.1045-1056

2011

Volltextzugriff (PDF)

Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription

Life (Basel, Switzerland), 2022-08, Vol.12 (9), p.1333

2022

Volltextzugriff (PDF)

Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases

Current topics in medicinal chemistry, 2017-01, Vol.17 (32), p.3425-3443

2017

Volltextzugriff (PDF)

Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides

Pharmaceutics, 2019-10, Vol.11 (11), p.568

2019

Volltextzugriff (PDF)

Spermidine/Spermine N1-Acetyltransferase 1 (SAT1)—A Potential Gene Target for Selective Sensitization of Glioblastoma Cells Using an Ionizable Lipid Nanoparticle to Deliver siRNA

Cancers, 2022-10, Vol.14 (21), p.5179

2022

Volltextzugriff (PDF)

Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model

Journal of controlled release, 2010-01, Vol.141 (2), p.145-152

2010

Volltextzugriff (PDF)

Peptide-mediated targeted drug delivery

Medicinal research reviews, 2012-05, Vol.32 (3), p.637-658

2012

Volltextzugriff (PDF)

Brain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC–MS/MS and Gd-DTPA Using Magnetic Resonance Imaging

Molecular pharmaceutics, 2016-02, Vol.13 (2), p.379-390

2016

Volltextzugriff (PDF)

Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases

Medicinal research reviews, 2002-03, Vol.22 (2), p.146-167

2002

Volltextzugriff (PDF)

The role of thiols and disulfides on protein stability

Current protein & peptide science, 2009-12, Vol.10 (6), p.614-625

2009

Volltextzugriff (PDF)

Drug Delivery: Principles and Applications

1, 2005

Volltextzugriff (PDF)

Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors

Peptides, 2003-03, Vol.24 (3), p.487-501

2003

Volltextzugriff (PDF)

Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors

Pharmaceutics, 2019-09, Vol.11 (9), p.481

2019

Volltextzugriff (PDF)

Noninvasive Brain Delivery and Efficacy of BDNF to Stimulate Neuroregeneration and Suppression of Disease Relapse in EAE Mice

Molecular pharmaceutics, 2020-02, Vol.17 (2), p.404-416, Article acs.molpharmaceut.9b00644

2020

Volltextzugriff (PDF)

Selective Uptake of Macromolecules to the Brain in Microfluidics and Animal Models Using the HAVN1 Peptide as a Blood-Brain Barrier Modulator

Molecular pharmaceutics, 2024-04, Vol.21 (4), p.1639-1652

2024

Volltextzugriff (PDF)

Enhancing Intestinal Absorption of a Model Macromolecule via the Paracellular Pathway using E-Cadherin Peptides

Journal of pharmaceutical sciences, 2021-05, Vol.110 (5), p.2139-2148

2021

Volltextzugriff (PDF)

Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor

The Journal of pharmacology and experimental therapeutics, 2007-08, Vol.322 (2), p.879-886

2007

Volltextzugriff (PDF)

Improving Brain Delivery of Biomolecules via BBB Modulation in Mouse and Rat: Detection using MRI, NIRF, and Mass Spectrometry

Nanotheranostics (Sydney, NSW), 2017, Vol.1 (2), p.217-231

2017

Volltextzugriff (PDF)

1 – 25 von 279

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(254)

Publikationsform

Artikel
(197)
Buchkapitel
(80)
Bücher
(2)

Sprache

Englisch
(279)

Erscheinungsjahr

n.n

Thema

Science & Technology
(191)
Life Sciences & Biomedicine
(176)
Pharmacology & Pharmacy
(120)
Humans
(64)
Animals
(53)
Biochemistry & Molecular Biology
(50)
Chemistry
(50)
Physical Sciences
(48)
Biological And Medical Sciences
(47)
Medical Sciences
(33)
Chemistry, Multidisciplinary
(32)
Chemistry, Medicinal
(29)
Pharmacology. Drug Treatments
(29)
Amino Acid Sequence
(27)
Peptides
(26)
Peptides, Cyclic - Chemistry
(26)
Intercellular Adhesion Molecule-1 - Metabolism
(22)
Mice
(22)
Protein Conformation
(21)
Blood-Brain Barrier
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles

Protein PEGylation for cancer therapy: bench to bedside

ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells

Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain Delivery

M. tuberculosis Transcription Machinery: A Review on the Mycobacterial RNA Polymerase and Drug Discovery Efforts

Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers

Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model

Controlling Ligand Surface Density Optimizes Nanoparticle Binding to ICAM-1

Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription

Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases

Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides

Spermidine/Spermine N1-Acetyltransferase 1 (SAT1)—A Potential Gene Target for Selective Sensitization of Glioblastoma Cells Using an Ionizable Lipid Nanoparticle to Deliver siRNA

Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model

Peptide-mediated targeted drug delivery

Brain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC–MS/MS and Gd-DTPA Using Magnetic Resonance Imaging

Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases

The role of thiols and disulfides on protein stability

Drug Delivery: Principles and Applications

Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors

Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors

Noninvasive Brain Delivery and Efficacy of BDNF to Stimulate Neuroregeneration and Suppression of Disease Relapse in EAE Mice

Selective Uptake of Macromolecules to the Brain in Microfluidics and Animal Models Using the HAVN1 Peptide as a Blood-Brain Barrier Modulator

Enhancing Intestinal Absorption of a Model Macromolecule via the Paracellular Pathway using E-Cadherin Peptides

Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor

Improving Brain Delivery of Biomolecules via BBB Modulation in Mouse and Rat: Detection using MRI, NIRF, and Mass Spectrometry

Suchergebnisse filtern